Navigation Links
deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
Date:2/7/2008

REYKJAVIK, Iceland, Feb. 7 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that it will host a live webcast of deCODE Chief Scientific Officer Jeffrey Gulcher's presentation at Biotechnology Industry Organization (BIO) CEO and Investor Conference.

The presentation will be delivered at 2:45 PM ET / 19:45GMT on Monday, February 11 at the Waldorf-Astoria hotel in New York. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.

About deCODE

deCODE genetics (Nasdaq: DCGN) is a global leader in applying human genetics to develop drugs and diagnostics for common diseases. Our population approach has enabled us to discover and target key biological pathways involved in conditions ranging from heart attack to cancer. We are turning these discoveries into new medicine to better treat and prevent many of the biggest challenges to public health. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com.

Contact:

deCODE genetics

Kristin H. Barkardottir

+354-570-2847

ir@decode.is


'/>"/>
SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
2. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
3. deCODE Launches deCODEme(TM)
4. deCODE genetics Announces Third Quarter 2007 Financial Results
5. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
6. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
7. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
8. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
9. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
10. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
11. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... NEW YORK , June 30, 2015  Today, Americord ... the U.S., announced Andrew Horne , a partner at ... Advisory Board. Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   ... appointment to Americord,s Advisory Board," says Martin Smithmyer , ... experience in his legal career that will assist Americord,s growth ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of ... currently outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, ... sale price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , ...
(Date:6/30/2015)... VANCOUVER , June 30, 2015 /PRNewswire/ - ... a clinical stage regenerative medicine company focused on ... the first participant in its Phase 1/2 clinical ... of chronic unilateral Achilles tendinosis, has been enrolled ... to intra-tendon ultrasound-guided injections. RCT-01 is comprised of ...
(Date:6/30/2015)... ... 2015 , ... Cannavoices , Inc., a premier legal ... and broadcast initiative. Produced by filmmakers, the multi-platform initiative aims to become not ... stories ever assembled. , Cannavoices profiles Advocates, Patients, Entrepreneurs, Growers, Investors, Ancillary ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
... N.J., Aug. 6 Millennium,Biotechnologies, Inc., a wholly ... Board: MBTG) today named Mark C.,Mirken its new ... of,Directors., Mirken has been President and Chief ... in September of 2007. Mirken will replace Jerry,Swon ...
... 6 Pressure,BioSciences, Inc. (Nasdaq: PBIO ) ... of its pressure cycling technology ("PCT")-enhanced,trypsin digestion application ... family of products. Named "Proteolysis (Trypsin)-PrEP", this new,PCT-enhanced ... & Development of Innovative Therapeutics Expo 2008, being ...
... Line with Company Estimates Highlighted by 11% Discovery ... Products and Services Growth -, ... CALP ) today reported second quarter financial,results for 2008. Revenues were ... year quarter of $35.3 million. Revenues were impacted,by a $3.5 million ...
Cached Biology Technology:Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. 2Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. 3Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 2Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 3Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 4Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 5Caliper Life Sciences Reports Second Quarter 2008 Results 2Caliper Life Sciences Reports Second Quarter 2008 Results 3Caliper Life Sciences Reports Second Quarter 2008 Results 4Caliper Life Sciences Reports Second Quarter 2008 Results 5Caliper Life Sciences Reports Second Quarter 2008 Results 6Caliper Life Sciences Reports Second Quarter 2008 Results 7Caliper Life Sciences Reports Second Quarter 2008 Results 8Caliper Life Sciences Reports Second Quarter 2008 Results 9
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... -- A new report [ 1 ... US consumers using mobile banking applications want their mobile devices ... voiceprint, instead of having to prove who they are with ... Identity   -   The Fusion of Financial Services, Mobile ... primary channel used by Gen X and Gen Y to ...
(Date:6/10/2015)... June 10, 2015 According ... Market by Technology (Ultrasound, TOF, Structured Light, Stereo ... Entertainment, Automotive) and by Geography - Trends & ... the market is expected to reach $3,319.71 Million ... between 2015 and 2020. Browse 71 ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 43D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4
... South Carolina, 7. Dezember 2012 /PRNewswire/ -- Integrated ... FBI-Zertifizierung seiner neuesten Fingerabdrucktechnologie einen weiteren technologischen ... das neue Produkt unter Verwendung der LES-Technologie ... Dünnfilmtransistor (Thin Film Transistor, TFT) her. Die ...
... New Rochelle, NY, December 6, 2012Enzymes play a crucial ... decreasing the energy consumption of biochemical reactions in many ... enhance the biocatalytic activity of an industrial enzyme are ... , a peer-reviewed journal from Mary Ann Liebert, Inc., ...
... and produce offspring of mixed ancestry? Recent genetic ... modern humans tens of thousands of years ago in ... pool. But the findings are not universally accepted, and ... role of interbreeding, which is also known as hybridization. ...
Cached Biology News:Integrated Biometrics stellt Sherlock vor - die weltweit leichtesten, dünnsten und kleinsten Appendix F Mobile ID-Fingerabdrucksensoren 2Can compressed fluids increase enzyme activity in industrial bioprocesses? 2Monkey business: What howler monkeys can tell us about the role of interbreeding in human evolution 2Monkey business: What howler monkeys can tell us about the role of interbreeding in human evolution 3
Purified anti-SOCS3...
Tumor Suppressor Sampler Kit 10 mu g each...
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice...
Umbilical cord blood eosinophils, For immunohistochemistry (IHC)...
Biology Products: